A detailed history of Mount Yale Investment Advisors, LLC transactions in Insmed Inc stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 1,685 shares of INSM stock, worth $274,975. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,685
Previous 3,397 50.4%
Holding current value
$274,975
Previous $259,000 34.75%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

SELL
$64.81 - $105.9 $110,954 - $181,300
-1,712 Reduced 50.4%
1,685 $169,000
Q1 2025

Apr 16, 2025

SELL
$65.25 - $83.83 $2,414 - $3,101
-37 Reduced 1.08%
3,397 $259,000
Q4 2024

Jan 22, 2025

SELL
$66.29 - $76.63 $7,822 - $9,042
-118 Reduced 3.32%
3,434 $237,000
Q3 2024

Oct 23, 2024

BUY
$62.0 - $79.01 $220,224 - $280,643
3,552 New
3,552 $259,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $22.1B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Mount Yale Investment Advisors, LLC Portfolio

Follow Mount Yale Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.